The Screener

Screen the market like a legend.

NASDAQ & NYSELive database
CK
Kirkpatrick ValueValue + Momentum
by Charles Kirkpatrick

Relatively low-valued stocks that have also outperformed over the last six months.

ValueMomentumGrowth
YTD
-19.4%
5Y
-83.5%
10Y
-64.7%
15Y
-77.4%
Total backtested return over each period.
Cumulative backtested growth
Kirkpatrick Value
+801%199920132026+49%
Growth of the screen since inception. Past performance does not guarantee future results.
8 of 8 stocks
Rank
Company
Exchange
Relative Earnings Growth
EPS-Growth 5yr
Relative Price Strength
% Rank-Rel Strength 26 week
% Rank-Price/Sales
Sales-Growth 5yr
1
AMNAMN Healthcare Services, Inc.
NYSE
315.4
-29.7
135.81
96
16
2.7
2
CNCCentene Corporation
NYSE
39.1
-44.4
123.98
89
8
11.1
3
CRBGCorebridge Financial, Inc.
NYSE
97.9
-21.8
116.10
56
29
4.3
4
FGF&G Annuities & Life, Inc.
NYSE
71.9
28.7
118.15
71
24
32.0
5
HELEHelen of Troy Limited
NASDAQ
50.5
-42.4
120.84
90
14
-3.2
6
DINOHF Sinclair Corporation
NYSE
83.4
23.1
130.36
95
21
19.2
7
VLOValero Energy Corporation
NYSE
32.5
33.0
122.29
94
27
14.0
8
VSTSVestis Corporation
NYSE
40.9
142.67
99
27
1.3

Ranked by the Kirkpatrick Value screen, updated from the live database. The columns are the exact criteria this strategy screens on. This is research, not investment advice.

Read the full Kirkpatrick Value analysis →How the screens work →
The strategy

All you need to know about Kirkpatrick Value

Discover the Value Screen by Kirkpatrick

Despite the success of his growth model, Kirkpatrick was concerned that its performance had occurred during one of the strongest bull markets in history. To protect against the inevitable market reversal, he wanted to strengthen the system against capital losses. His belief was that relative price strength would not be effective in a market downturn and could be the source of significant capital losses. Kirkpatrick's alternative was to reduce portfolio risk by starting with a group of low-valued stocks. His reasoning was that since the low valuations were likely due to price declines, the downside risk had been reduced. Kirkpatrick arbitrarily selected only stocks in the 30th percentile or lower using relative price-to-sales percentiles.

He tested his value model from 1998 to 2007. It outperformed the growth model and the S&P 500 Index.

Kirkpatrick's Value List mimics the Growth List. However, instead of using a chart pattern stop, it uses the relative price-to-sales ratio to reduce risk.

Rule #1 Price Strength

In Beat the Market, Kirkpatrick calculates relative strength by dividing the current weekly closing price by the 26-week moving average of closing prices. We only keep the company in the top 10%.

Top 10% of Relative Price Strength

Rule #2 Reported Earnings Growth

Kirkpatrick uses a non-standard calculation for earnings growth, which compares operating income over the last four fiscal quarters to the four-quarter total of operating income one quarter earlier. His goal is to eliminate the effect of seasonality on a company's earnings.

Growth in Operating Income

Rule #3 Price and Market Cap

For the Value List, Kirkpatrick relaxed his market cap requirements to include companies with a market capitalization of $500 million or more. However, he maintained the minimum share price of $10.

Share Price > $10

Market Cap > $500 million

Rule #4 Relative Valuation

For his Value List, Kirkpatrick selects stocks with relative price-to-sales ratios in the 30th percentile or lower.

Top 30% for Relative Price/Sales

Rule #5 Sell Criteria

After buying a stock for his value list, Kirkpatrick used these rules to determine when to remove a stock from the portfolio:

  • Relative price strength percentile of 30 or less,
  • Relative reported earnings growth percentile below 50, and
  • Stocks NOT removed for extraordinarily high relative price-to-sales ratios.
The Screener | GuruScreener